Skip to main content
Clinical Trials/CTRI/2023/03/050527
CTRI/2023/03/050527
Not yet recruiting
未知

A clinical trial to evaluate the safety and efficacy of TATC/HT/001 as a treatment modality in hyperthyroidism. - Nil

Ayurgenics Ayurveda Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E059- Thyrotoxicosis, unspecified
Sponsor
Ayurgenics Ayurveda Private Limited
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Ayurgenics Ayurveda Private Limited

Eligibility Criteria

Inclusion Criteria

  • 1\.Adult males or females,greater than or equal to 18yr age with a diagnosis of Gravesâ??disease ( Hyperthyroidism)
  • 2\.Gravesâ?? disease (Hyperthyroidism) defined as raised T4 and/or T3
  • 3\.low TSH with or without hypermetabolic symptoms

Exclusion Criteria

  • Pregnancy/planning pregnancy in next 01 yr, use of Antithyroid drugs, iodine containing drugs, Multinodular goiter, thyroid malignancy/suspicious nodules, significant eye disease, Refusal to give consent

Outcomes

Primary Outcomes

Not specified

Similar Trials